CIC CBIC Certified Infection Control Exam Free Practice Exam Questions (2026 Updated)

The Plan, Do, Study, Act (PDSA) model is a widely used performance improvement tool in infection prevention. It focuses on continuous quality improvement through planning, implementing, analyzing data, and making adjustments. This model aligns with infection control program evaluations and The Joint Commission’s infection prevention and control standards.

Why the Other Options Are Incorrect?

A. Six Sigma – A data-driven process improvement method but not as commonly used in infection control as PDSA.

B. Failure Mode and Effects Analysis (FMEA) – Used to identify risks before implementation, rather than ongoing evaluation.

D. Root Cause Analysis (RCA) – Used to analyze failures after they occur, rather than guiding continuous improvement.

CBIC Infection Control Reference

The PDSA cycle is a recognized model for evaluating and improving infection control plans​.

The Certification Study Guide (6th edition) emphasizes that restoration of a safe environment of care following construction or renovation is essential before patient occupancy. A primary concern after construction is the potential contamination and disruption of the heating, ventilation, and air conditioning (HVAC) system, which plays a critical role in infection prevention by controlling airflow, pressure relationships, and filtration.

Inspecting and cleaning air ducts as needed—and ensuring that the ventilation system is properly balanced—helps confirm that airflow is functioning as designed, including appropriate air exchanges, pressure differentials, and filtration efficiency. The study guide highlights that construction activities can introduce dust, debris, and microorganisms (including fungal spores) into ductwork, which may subsequently be disseminated into patient care areas if not addressed. Proper HVAC verification is a key component of post-construction clearance following an Infection Control Risk Assessment (ICRA).

The other options are not recommended as routine first steps. Air sampling is not advised because results are difficult to interpret and do not reliably predict infection risk. Stocking supplies before environmental clearance risks contamination of clean items. Routine water testing is not required unless water system disruption or stagnation occurred and is guided by a facility’s water management program rather than construction completion alone.

CIC exam questions frequently test post-construction readiness activities, reinforcing that HVAC inspection, cleaning, and balancing are critical prerequisites for safely reopening patient care spaces.

The Certification Study Guide (6th edition) explains that interpretation of hepatitis B serologic markers is a fundamental competency for infection preventionists, particularly in occupational health and exposure management. In this scenario, the patient is HBsAg negative, indicating no current hepatitis B infection; anti-HBs positive, indicating immunity; and anti-HBc negative, meaning there has been no prior natural infection with hepatitis B virus.

This specific serologic pattern is diagnostic of immunity due to vaccination. The hepatitis B vaccine contains only purified hepatitis B surface antigen, not core antigen. As a result, vaccinated individuals develop antibodies to the surface antigen (anti-HBs) but do not develop antibodies to the core antigen (anti-HBc). The study guide emphasizes this distinction as the key factor in differentiating vaccine-induced immunity from immunity due to past infection.

The incorrect options reflect different serologic patterns. Previous hepatitis B infection would produce a positive anti-HBc result. A recent blood transfusion does not confer long-term immunity or this marker pattern. Low-level infectivity would require detectable surface antigen or core antibody.

This question reflects a classic CIC exam topic: recognizing the serologic profile of vaccine-induced immunity. Correct interpretation supports appropriate employee health decisions, post-exposure management, and immunization program evaluation.

The Certification Study Guide (6th edition) classifies endovaginal ultrasound probes as semi-critical devices because they come into contact with mucous membranes. As such, they require high-level disinfection (HLD) between patients, not sterilization, unless the manufacturer specifically requires it. This immediately eliminates option A, which incorrectly states sterilization is required.

Option B is incorrect because probe covers or sheaths do not eliminate the risk of contamination. Numerous studies referenced in infection prevention literature and reflected in the study guide demonstrate that probe covers can fail, tear, or leak, allowing microorganisms—including viruses—to contaminate the probe surface. Therefore, HLD is required regardless of sheath use.

Option C is incorrect because critical items, by definition, enter sterile tissue or the vascular system. Endovaginal probes contact mucous membranes only and are therefore not critical items under the Spaulding Classification System.

Option D is correct because endovaginal probes may be contaminated with human papillomavirus (HPV) prior to examination, even when probe covers are used. HPV is particularly concerning due to its resistance to some low-level disinfectants and its ability to persist on surfaces. The study guide highlights HPV as a key organism driving strict reprocessing requirements for these probes.

This question reflects a high-yield CIC exam concept: probe covers do not replace high-level disinfection, and viral contamination—including HPV—remains a significant risk.

Immediate feedback is a best practice in behavior correction and performance improvement. In hand hygiene non-compliance, real-time intervention allows for immediate correction, education, and reinforcement of infection prevention policies.

The APIC/JCR Workbook recommends:

“Provide simulation training… that provides immediate feedback—for example, how to properly insert a urinary catheter or perform hand hygiene.” This supports behavior change and staff learning.

The APIC Text emphasizes that real-time, direct feedback is more effective than passive measures like signage or delayed education campaigns.

The CBIC Certified Infection Control Exam Study Guide (6th edition) emphasizes that the most important consideration in assigning expiration dates to sterile supplies is package integrity, reflecting the principle of event-related sterility. Modern infection prevention practice recognizes that sterility is not determined by time alone but by whether an event has occurred that compromises the sterile barrier system.

Sterile items remain sterile indefinitely as long as the packaging remains intact, dry, and properly stored, and no contamination event (such as tearing, puncture, moisture exposure, or improper handling) has occurred. Therefore, the presence or absence of a printed expiration date is less important than assurance that the package integrity has been maintained throughout storage and handling.

Option A is correct because it captures the foundational concept that sterility is directly linked to the integrity of the packaging, not an arbitrary time frame. Option B is incorrect because fixed time-based expiration dates (e.g., 30–90 days) are outdated and not evidence-based. Options C and D may influence packaging durability or compatibility with sterilization methods, but they are secondary considerations and do not override the primary determinant of sterility.

For the CIC® exam, this question reinforces a critical sterilization principle: event-related shelf life is the standard, and infection preventionists should focus on policies that emphasize package integrity, proper storage conditions, and handling practices rather than routine time-based expiration dating.

The Certification Study Guide (6th edition) identifies coagulase-negative staphylococci (CoNS) as among the most common causes of surgical site infections following orthopedic implant procedures, including total hip replacement. These organisms are part of normal human skin flora and are therefore a frequent source of contamination during surgery, even when aseptic technique is followed. Their importance is heightened in procedures involving prosthetic material because CoNS have a strong ability to adhere to foreign bodies and form biofilms, which protect bacteria from host defenses and antimicrobial therapy.

The study guide emphasizes that SSIs following joint replacement procedures often present within 30 to 60 days postoperatively and are typically caused by gram-positive cocci, particularly Staphylococcus aureus and coagulase-negative staphylococci. CoNS are especially associated with indolent or delayed infections involving implanted devices, making them a critical teaching point in joint replacement programs.

The other organisms listed are less likely causes in this setting. Escherichia coli and Pseudomonas aeruginosa are more commonly associated with gastrointestinal, urinary, or moist environmental sources rather than clean orthopedic procedures. Group A streptococci may cause acute SSIs but are far less common in prosthetic joint infections.

Understanding organism-specific risks allows infection preventionists to target prevention strategies, antimicrobial prophylaxis, and surveillance effectively—key competencies tested on the CIC exam.

The CBIC Certified Infection Control Exam Study Guide (6th edition) identifies prion diseases (such as Creutzfeldt-Jakob disease) as unique and extremely challenging from an infection prevention standpoint due to the extraordinary resistance of prions to conventional disinfection and sterilization methods. Prions are not destroyed by standard high-level disinfection, low-temperature sterilization, ethylene oxide, or hydrogen peroxide gas plasma, even when manufacturer instructions for use suggest these methods for routine pathogens.

Invasive neurologic procedures involving high-risk tissues (brain, spinal cord, posterior eye) pose the greatest transmission risk. When a reusable device such as an endoscope is used on high-risk tissue in a patient with known or suspected prion disease, and the device cannot tolerate validated prion-inactivation protocols, the Study Guide recommends removal from service and disposal.

While harsh chemical treatments such as 1N sodium hydroxide or high-concentration bleach combined with extended steam sterilization may be effective for heat-resistant surgical instruments, flexible endoscopes and similar devices cannot safely undergo these processes without damage. Therefore, reprocessing is not acceptable in this scenario.

Autoclaving alone and low-temperature sterilization methods are ineffective against prions. As a result, the safest and recommended action is to bag the device as biohazardous waste and discard it, preventing any risk of iatrogenic transmission.

For the CIC® exam, this question tests recognition that manufacturer IFUs do not supersede prion-specific infection prevention guidance, and patient safety requires device destruction when prion exposure cannot be reliably mitigated.

The Certification Study Guide (6th edition) emphasizes that an outbreak should be suspected when there is an unexpected clustering of infections by time, place, and person, particularly when cases share a common exposure or procedure. Option D meets all key criteria for outbreak suspicion: the same organism (methicillin-resistant Staphylococcus aureus), the same location (cardiac ICU), a common procedure (cardiac surgery), and a tight time frame (same week). This constellation strongly suggests possible transmission related to surgical practices, postoperative care, or shared equipment.

The other scenarios reflect situations that do not necessarily indicate an outbreak. Routine environmental cultures are not recommended for outbreak detection and often do not correlate with patient infection risk. An apparent increase in ventilator-associated pneumonia following implementation of a new case definition is likely due to surveillance artifact, not true transmission. Similarly, increases in carbapenemase-producing Klebsiella pneumoniae after adoption of new laboratory breakpoints reflect diagnostic changes, not an epidemiologic event.

The study guide stresses the importance of distinguishing true outbreaks from pseudo-outbreaks caused by changes in definitions, testing methods, or surveillance intensity. CIC exam questions frequently test this concept. Recognizing a true outbreak requires linking cases through epidemiologic characteristics—not simply increases in numbers.

Prompt recognition of true outbreaks enables timely investigation, implementation of control measures, and prevention of further transmission.

The Certification Study Guide (6th edition) emphasizes that the primary goal of surgical instrument cleaning is to remove organic and inorganic soil while preserving the integrity and functionality of the instrument. For this reason, detergents with a neutral pH are considered the best choice for routine surgical instrument cleaning and material compatibility.

Neutral pH detergents are effective at removing blood, tissue, and other organic matter without causing corrosion, pitting, or degradation of metals, plastics, seals, and coatings commonly used in surgical instruments. The study guide notes that repeated exposure to harsh chemical environments can damage instruments, compromise device performance, and shorten instrument lifespan—ultimately affecting patient safety and increasing replacement costs.

Acidic detergents may be used selectively for removal of mineral deposits or water scale but are not appropriate for routine cleaning due to their corrosive potential. Sodium hypochlorite (bleach) is strongly discouraged for surgical instruments because it is highly corrosive and can rapidly damage stainless steel. Quaternary ammonium compounds are low-level disinfectants and are not suitable for cleaning critical or semi-critical medical devices prior to disinfection or sterilization.

This question reflects a high-yield CIC exam principle: effective cleaning must balance soil removal with material compatibility. Neutral pH detergents best meet both requirements and are widely recommended by manufacturers and reprocessing standards for surgical instrumentation.

Multi-drug resistant (MDR) Klebsiella pneumoniae in a high-risk area like the ICU requires urgent investigation because:

It spreads rapidly via contaminated hands or equipment.

It poses a serious risk to immunocompromised patients.

An outbreak could lead to severe hospital-acquired infections (HAIs).

Why the Other Options Are Incorrect?

A. One blood isolate of Streptococcus agalactiae in the nursery – Single cases are not indicative of an outbreak.

B. Two isolates of Staphylococcus aureus in postoperative surgical sites – Common post-surgical pathogen; requires monitoring but not immediate outbreak investigation.

D. Two blood isolates of coagulase-negative staphylococci in the oncology unit – Common contaminants in blood cultures and not immediately alarming.

CBIC Infection Control Reference

APIC guidelines prioritize investigating MDR pathogens in high-risk units, such as ICU, to prevent transmission​.

A process measure assesses how well healthcare personnel follow specific procedures known to prevent infection. In the case of CAUTI (Catheter-Associated Urinary Tract Infection), monitoring staff compliance with proper insertion technique is a direct process measure.

According to the APIC/JCR Workbook, effective CAUTI prevention involves evaluating compliance with proper catheter insertion and maintenance practices. Monitoring this behavior is a process measure that directly affects outcomes like infection rate reduction.

The CBIC Study Guide also emphasizes using compliance with evidence-based insertion techniques as a strategy to measure and improve CAUTI prevention efforts.

APIC Text notes that “a process measure focuses on a process or the steps in a process that leads to a specific outcome.” This includes monitoring healthcare staff performance related to proper catheter insertion and care.

Incorrect answer rationale:

A. CAUTI rate per 1000 catheter days – This is an outcome measure, not a process measure.

B. Standardized Infection Ratio per unit – Also an outcome/benchmarking metric.

C. Rate of bloodstream infections secondary to CAUTI – This is an outcome, not a process.

The correct answer is A, "Observe all steps for reprocessing," as this is the most important process for the infection preventionist (IP) to review when evaluating a third-party reprocessor for single-use devices. According to the Certification Board of Infection Control and Epidemiology (CBIC) guidelines, the reprocessing of single-use devices (SUDs) by third-party entities must adhere to stringent infection control standards to ensure they are safe for reuse and do not contribute to healthcare-associated infections (HAIs). Observing all steps—such as cleaning, disinfection, sterilization, packaging, and quality control—allows the IP to directly assess compliance with manufacturer instructions, regulatory requirements (e.g., FDA guidelines), and best practices (e.g., AAMI ST91) (CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competency 3.3 - Ensure safe reprocessing of medical equipment). This hands-on evaluation is critical because any deviation in the reprocessing chain can compromise device sterility and patient safety.

Option B (review the facility's blueprints and policies) provides context about the physical layout and procedural framework, but it is a preliminary step that does not directly verify the reprocessing process’s effectiveness. Option C (ensure air and water cultures are performed regularly) is important for monitoring environmental contamination risks, particularly in sterile processing areas, but it is a supportive measure rather than the primary focus of evaluating the reprocessor’s core activities. Option D (obtain feedback from other IPs who use the reprocessor) offers valuable peer insights, but it is subjective and secondary to direct observation, which provides firsthand evidence of compliance and performance.

The priority on observing reprocessing steps aligns with CBIC’s emphasis on ensuring the safety and efficacy of reprocessed medical devices, a key responsibility for IPs when outsourcing to third-party reprocessors (CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competency 3.5 - Evaluate the environment for infection risks). This process enables the IP to identify specific weaknesses, validate adherence to standards, and make informed decisions about the reprocessor’s suitability.

When investigating a possible cluster of infections, an infection preventionist (IP) follows a structured epidemiological approach to identify the cause and implement control measures. The Certification Board of Infection Control and Epidemiology (CBIC) outlines this process within the "Surveillance and Epidemiologic Investigation" domain, which aligns with the Centers for Disease Control and Prevention (CDC) guidelines for outbreak investigation. The steps typically include defining and identifying cases, formulating a hypothesis, testing the hypothesis, and implementing control measures. The question specifies the next step after defining and identifying cases, requiring an evaluation of the logical sequence.

Option C, "A hypothesis that will explain the majority of cases," is the next critical step. After confirming a cluster through case definition and identification (e.g., by time, place, and person), the IP should develop a working hypothesis to explain the observed pattern. This hypothesis might propose a common source (e.g., contaminated equipment), a mode of transmission (e.g., airborne), or a specific population at risk. The CDC’s "Principles of Epidemiology in Public Health Practice" (3rd Edition, 2012) emphasizes that formulating a hypothesis is essential to guide further investigation, such as identifying risk factors or environmental sources. This step allows the IP to focus resources on testing the most plausible explanation before proceeding to detailed analysis or interventions.

Option A, "The route of transmission," is an important element of the investigation but typically follows hypothesis formulation. Determining the route (e.g., contact, droplet, or common vehicle) requires data collection and analysis to test the hypothesis, making it a subsequent step rather than the immediate next action. Option B, "An appropriate control group," is relevant for analytical studies (e.g., case-control studies) to compare exposed versus unexposed individuals, but this is part of hypothesis testing, which occurs after the hypothesis is established. Selecting a control group prematurely, without a hypothesis, lacks direction and efficiency. Option D, "Whether observed incidence exceeds expected incidence," is a preliminary step to define a cluster, often done during case identification using baseline data or statistical thresholds (e.g., exceeding the mean plus two standard deviations). Since the question assumes cases are already defined and identified, this step is complete, and the focus shifts to hypothesis development.

The CBIC Practice Analysis (2022) and CDC guidelines prioritize hypothesis formulation as the logical next step after case identification, enabling a targeted investigation. This approach ensures that the IP can efficiently address the cluster’s cause, making Option C the correct answer.

An Ishikawa diagram (fishbone diagram) is used to visually represent cause-and-effect relationships in problem analysis. It is best for summarizing and categorizing issues found in a gap analysis related to infection prevention.

The APIC Text confirms:

“A fishbone diagram (also called a tree diagram or Ishikawa) allows a team to identify, explore, and graphically display all of the possible causes related to a problem to discover the root cause”.

It’s particularly useful in quality improvement and infection prevention project analysis.

The correct answer is A, "One dose of Tdap vaccine," as this is the recommended immunization for a 55-year-old nurse who received all childhood vaccinations. According to the Certification Board of Infection Control and Epidemiology (CBIC) guidelines, which align with recommendations from the Centers for Disease Control and Prevention (CDC) and the Advisory Committee on Immunization Practices (ACIP), adults who have completed a primary series of childhood vaccinations (typically 5 doses of DTaP or DTP) should receive a single booster dose of Tdap if they have not previously received it. This is especially critical for healthcare personnel, such as a 55-year-old nurse, due to their increased risk of exposure to pertussis and the need to protect vulnerable patients (CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competency 3.2 - Implement measures to prevent transmission of infectious agents). The Tdap vaccine, which protects against tetanus, diphtheria, and pertussis, is recommended once between ages 11-64, with a preference for administration in early adulthood (e.g., 19-26 years) or as soon as feasible for older adults, including this 55-year-old nurse, to ensure immunity against pertussis, which wanes over time. For individuals aged 65 and older, Tdap is still recommended if not previously received, though Tdap is preferred over Td (tetanus and diphtheria only) for healthcare workers to address pertussis risk.

Option B (two doses of Tdap vaccine at least 14 days apart) and Option C (two doses of Tdap vaccine at least 28 days apart) are not standard recommendations for adults with a complete childhood vaccination history. Multiple doses are typically reserved for individuals with incomplete primary series or specific high-risk conditions, not for this scenario. Option D (no additional vaccination is recommended) is incorrect because, even with a complete childhood series, a Tdap booster is advised for healthcare workers to maintain protection, especially given the nurse’s occupational exposure risks (CDC Immunization Schedules, 2024). After receiving the Tdap booster, a Td booster every 10 years is recommended to maintain tetanus and diphtheria immunity, but the initial Tdap dose is the priority for this nurse.

The recommendation for one Tdap dose aligns with CBIC’s emphasis on evidence-based immunization policies to prevent transmission of vaccine-preventable diseases in healthcare settings (CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competency 3.1 - Collaborate with organizational leaders). This ensures the nurse is protected and contributes to herd immunity, reducing the risk of pertussis outbreaks in the healthcare environment.

The CBIC Certified Infection Control Exam Study Guide (6th edition) identifies inadequate hand hygiene as the most common and significant factor associated with healthcare-associated transmission of methicillin-resistant Staphylococcus aureus (MRSA). MRSA is primarily transmitted via direct contact, most often through the hands of healthcare personnel after contact with colonized or infected patients or contaminated environmental surfaces.

While MRSA-infected or colonized patients serve as reservoirs for the organism, transmission does not occur unless there is a breakdown in infection prevention practices, particularly hand hygiene. Numerous studies and surveillance findings cited in the Study Guide demonstrate that adherence to hand hygiene protocols—before and after patient contact, after contact with bodily fluids, and after contact with the patient environment—is the single most effective measure to reduce MRSA spread within healthcare facilities.

Improper ventilation (Option A) is associated with airborne pathogens, not MRSA, which is not transmitted via the airborne route. MRSA-colonized healthcare workers (Option D) are far less commonly implicated in transmission than transient hand contamination, and routine screening of staff is not recommended except during specific outbreak investigations. Option B describes a reservoir, not the primary mechanism of transmission.

For CIC® exam purposes, this question reinforces a foundational principle of infection prevention: failure to perform appropriate hand hygiene is the leading cause of healthcare-associated MRSA transmission, making it the correct and best answer.

The CBIC Certified Infection Control Exam Study Guide (6th edition) clearly outlines recommendations for postexposure chemoprophylaxis following invasive meningococcal disease, which is caused by Neisseria meningitidis. This organism is transmitted through direct contact with respiratory secretions or saliva, such as through kissing, sharing eating utensils, or prolonged close household contact.

Household members are considered high-risk close contacts because they have sustained, close exposure to the patient’s respiratory droplets and oral secretions. As a result, they should receive chemoprophylaxis as soon as possible, ideally within 24 hours of identification of the index case, to prevent secondary cases. This recommendation applies regardless of vaccination status.

The other options do not meet criteria for prophylaxis. Healthcare personnel exposed only to urine or feces (Option B) are not at risk, as N. meningitidis is not transmitted via these routes. Casual school contact or sharing supplies (Option C) does not constitute close exposure to respiratory secretions. Athletic teammates (Option D) generally do not require prophylaxis unless there was direct exposure to saliva (e.g., sharing water bottles or mouthguards).

For CIC® exam preparation, it is essential to recognize that chemoprophylaxis is limited to close contacts with direct exposure to respiratory secretions, with household members being the most consistent and clearly defined group requiring prophylaxis.

The CBIC Certified Infection Control Exam Study Guide (6th edition) emphasizes that successful implementation of infection prevention recommendations depends on effective communication, engagement, and education tailored to the audience. Healthcare departments differ significantly in workflow, patient population, risk profile, and daily practices. Therefore, providing targeted, understandable education to staff is the most effective strategy to ensure recommendations are adopted and sustained.

Option A reflects best practice by aligning infection prevention guidance with the specific roles and responsibilities of staff in each department. Education that uses relevant examples, scenarios, and language improves comprehension, promotes buy-in, and supports behavior change. The Study Guide highlights that adult learners benefit most from education that is practical, interactive, and clearly applicable to their work environment.

Options B and C are ineffective because generic or non-customized approaches often fail to address department-specific challenges and may lead to confusion or poor compliance. Avoiding department-specific training ignores variations in risk and undermines accountability. Option D relies solely on enforcement rather than collaboration, which can result in resistance and decreased adherence.

For the CIC® exam, this question reinforces that infection prevention programs function best when they act as educators and partners, not just policy enforcers. Tailored education empowers staff, enhances compliance, and ultimately improves patient safety outcomes across diverse healthcare settings.